OPRX vs HCAT
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 19, 2026
OPRX
HCAT
Investment Advisor Scores
HCAT
AI Analyst Insights
Detailed Metrics Comparison
| Metric | OPRX | HCAT | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 5.6306 | 10 | OPRX |
| PEG Ratio | 1.6078 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -29.8% | -12.7% | HCAT |
| Earnings Growth | -66.8% | 0.0% | HCAT |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.5/100 | 52.1/100 | HCAT |
| Profit Margin | 4.7% | -90.6% | OPRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | BUY | HCAT |
Relative Price Performance (Last 90 Days)
Current Technical Phase
OPRX
MarkupPrice above SMA50, rising 50-day trend (9.7% over 20 days), RSI 56
HCAT
DistributionPrice near a flattening SMA50 (slope -9.2%) with fading momentum, RSI 46
Fundamentals Snapshot
| Metric | OPRX | HCAT |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 8.1 | 230.0 |
| Trailing P/E | 36.9 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.3% | -0.1% |
| Gross Margin | 0.7% | 0.5% |
| Operating Margin | 0.0% | -0.1% |
| EPS | 0.24 | -3.69 |
| Dividend Yield | — | — |